{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:26:12Z","timestamp":1789503972007,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    \u03b2-thalassemia is a prevalent genetic disorder in Iraq, leading to significant health issues due to reduced hemoglobin production. The DNA sequencing technique was used to explore genetic variations and their clinical implications. Our findings have the potential to inform diagnosis, guide targeted therapeutic approaches, and enhance genetic counseling to reduce long-term morbidity in affected individuals. Peripheral blood samples were collected from 100 patients for analysis. Quantitative measurements included complete blood count (CBC), ferritin, parathyroid hormone (PTH), lactate dehydrogenase (LDH), 25\u2011hydroxyvitamin D, phosphorus, calcium, and bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA). We detected 18 \u03b2-globin mutations in \u03b2-thalassemia patients by direct Sanger sequencing, of which two were novel (HBB:c.315\u2009+\u2009l08A&gt;G and HBB:c.316-151A\u2009&gt;\u2009G). Additionally, four mutations (IVS-II-1G\u2009&gt;\u2009A, IVS-II-5G\u2009&gt;\u2009C, IVS-I-110G\u2009&gt;\u2009A, and HBB:c.440A\u2009&gt;\u2009C) have been previously reported as pathogenic. This research pinpointed four \u03b2-globin gene pathogenic mutations as having significant associations with clinical parameters. Hematological parameters (HGB, WBC, RBC indices, RBC count) and biochemical\/metabolic markers (phosphorus, PTH, LDH, ferritin, vitamin D3, calcium, ALP) exhibited strong statistical differences (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001\u20130.020) across mutation groups. Bone health markers (BMC, BMD) and red blood cell indices (MCH, MCHC, MCV, MPV) also showed significant variation (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001\u20130.002). In contrast, platelet count (PLT) did not differ significantly (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.331). These findings highlight mutation specific impacts on hematological, metabolic, and skeletal systems in the studied population.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0344034","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:31:14Z","timestamp":1772649074000},"page":"e0344034","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic variations and clinical implications of B-thalassemia in Iraqi population"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2469-9444","authenticated-orcid":true,"given":"Ayman Ziadoon","family":"Jawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Chelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah Hashim","family":"AL-Zuhairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanen","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"6","key":"pone.0344034.ref001","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3324\/haematol.2018.206060","article-title":"The carrier state for sickle cell disease is not completely harmless","volume":"104","author":"JZ Xu","year":"2019","journal-title":"Haematologica"},{"key":"pone.0344034.ref002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","article-title":"Sickle-cell trait: novel clinical significance","volume":"2010","author":"NS Key","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"pone.0344034.ref003","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcmd.2017.06.001","article-title":"Molecular basis of \u03b2 thalassemia and potential therapeutic targets","volume":"70","author":"SL Thein","year":"2018","journal-title":"Blood Cells Mol Dis"},{"issue":"18","key":"pone.0344034.ref004","article-title":"\u03b2-Thalassemia gene editing therapy: Advancements and difficulties","volume":"103","author":"J Hu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"pone.0344034.ref005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"J Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"pone.0344034.ref006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4939-2365-6_10","article-title":"In silico PCR primer designing and validation","volume":"1275","author":"A Kumar","year":"2015","journal-title":"Methods Mol Biol"},{"key":"pone.0344034.ref007","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt911","article-title":"Updates of the HbVar database of human hemoglobin variants and thalassemia mutations","volume":"42","author":"B Giardine","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"pone.0344034.ref008","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"C Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"pone.0344034.ref009","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"MJ Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0344034.ref010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13073-024-01421-5","article-title":"HGVS Nomenclature 2024: improvements to community engagement, usability, and computability","volume":"16","author":"RK Hart","year":"2024","journal-title":"Genome Med"},{"issue":"5","key":"pone.0344034.ref011","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"pone.0344034.ref012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","volume":"2017","author":"AT Taher","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"pone.0344034.ref013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2017.09.012","article-title":"Bone disease in \u03b2 thalassemia patients: past, present and future perspectives","volume":"80","author":"V De Sanctis","year":"2018","journal-title":"Metabolism"},{"issue":"12","key":"pone.0344034.ref014","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)","volume":"115","author":"E Voskaridou","year":"2010","journal-title":"Blood"},{"issue":"08","key":"pone.0344034.ref015","first-page":"331","article-title":"Low serum 25-hydroxyvitamin D among beta-thalassemia patients in Iraq","volume":"10","author":"R AlMosawi","year":"2018","journal-title":"Journal of Global Pharma Technology"},{"issue":"4","key":"pone.0344034.ref016","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0016-5085(85)80001-9","article-title":"Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status","volume":"88","author":"LH Chow","year":"1985","journal-title":"Gastroenterology"},{"issue":"6","key":"pone.0344034.ref017","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"GJ Kato","year":"2006","journal-title":"Blood"},{"issue":"9","key":"pone.0344034.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204283","article-title":"Role of altered proteostasis network in chronic hypobaric hypoxia induced skeletal muscle atrophy","volume":"13","author":"A Agrawal","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"pone.0344034.ref019","article-title":"Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis","volume":"8","author":"R Lu","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"pone.0344034.ref020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/01676830.2010.513591","article-title":"\u03b2-Thalassemia mutations in the Kurdish population of northeastern Iraq","volume":"34","author":"SD Jalal","year":"2010","journal-title":"Hemoglobin"},{"issue":"1","key":"pone.0344034.ref021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MPH.0000000000001656","article-title":"Clinical Laboratory Manifestation and Molecular Diagnosis of \u03b2-Thalassemia Patients in Iraq","volume":"42","author":"RHN AlMosawi","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"pone.0344034.ref022","first-page":"129","article-title":"The Spectrum of beta-Thalassemia Mutations in the Arab Populations","volume":"1","author":"L Zahed","year":"2001","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"pone.0344034.ref023","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/03630260701459382","article-title":"The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran","volume":"31","author":"AA Kiani","year":"2007","journal-title":"Hemoglobin"},{"issue":"4","key":"pone.0344034.ref024","first-page":"231","article-title":"Spectrum of HBB mutations in Iraqi patients with hemoglobinopathies","volume":"44","author":"NA Al-Allawi","year":"2020","journal-title":"Hemoglobin"},{"issue":"2","key":"pone.0344034.ref025","first-page":"69","article-title":"Distribution of \u03b2-Globin Gene Mutations in Thalassemia Minor Population of Kerman Province, Iran","volume":"39","author":"N Saleh-Gohari","year":"2010","journal-title":"Iran J Public Health"},{"issue":"2","key":"pone.0344034.ref026","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/03630269.2011.553567","article-title":"Spectrum of \u03b2-thalassemia mutations in the eastern province of Saudi Arabia","volume":"35","author":"A Al-Sultan","year":"2011","journal-title":"Hemoglobin"},{"key":"pone.0344034.ref027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000086186","article-title":"Mutations associated with beta-thalassemia intermedia in Kuwait","author":"A Adekile","year":"2005","journal-title":"Med Princ Pract"},{"key":"pone.0344034.ref028","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.5897\/AJB09.1763","article-title":"Thalassemia mutations in Gaziantep, Turkey","volume":"9","author":"S Pehlivan","year":"2010","journal-title":"Afr J Biotechnol"},{"key":"pone.0344034.ref029","first-page":"1","article-title":"The complete spectrum of beta (\u03b2) thalassemia mutations in Bangladeshi population","volume":"3","author":"G Sultana","year":"2016","journal-title":"Austin Biomarkers Diagn"},{"issue":"1","key":"pone.0344034.ref030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/03630269.2017.1302468","article-title":"The Frequency of HBB Mutations Among \u03b2-Thalassemia Patients in Hamadan Province, Iran","volume":"41","author":"M Jalilian","year":"2017","journal-title":"Hemoglobin"},{"issue":"4","key":"pone.0344034.ref031","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/03630269.2011.588508","article-title":"Molecular basis of \u03b2-thalassemia in the western province of Saudi Arabia: identification of rare \u03b2-thalassemia mutations","volume":"35","author":"AM Abuzenadah","year":"2011","journal-title":"Hemoglobin"},{"issue":"6","key":"pone.0344034.ref032","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.blre.2016.07.001","article-title":"Beta thalassemia in 31,734 cases with HBB gene mutations: Pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East","volume":"30","author":"N Mahdieh","year":"2016","journal-title":"Blood Rev"},{"issue":"4","key":"pone.0344034.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174637","article-title":"Investigation of mutations in the HBB gene using the 1,000 genomes database","volume":"12","author":"T Carlice-Dos-Reis","year":"2017","journal-title":"PLoS One"},{"key":"pone.0344034.ref034","first-page":"1","article-title":"Mechanisms regulating the reactions of human hemoglobin","volume":"18","author":"MF Perutz","year":"1989","journal-title":"Annu Rev Biophys Biophys Chem"},{"issue":"1","key":"pone.0344034.ref035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0006-3495(98)77529-0","article-title":"A helix propensity scale based on experimental studies of peptides and proteins","volume":"75","author":"CN Pace","year":"1998","journal-title":"Biophys J"},{"issue":"3","key":"pone.0344034.ref036","article-title":"Hemoglobin variants: biochemical properties and clinical correlates","volume":"3","author":"CS Thom","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"pone.0344034.ref037","first-page":"87","article-title":"Consanguinity and genetic disorders in Arab populations","volume":"10","author":"H Hamamy","year":"2007","journal-title":"Commun Genet"},{"key":"pone.0344034.ref038","volume-title":"Prevention of thalassemias and other hemoglobin disorders","author":"M Angastiniotis","year":"2013"},{"key":"pone.0344034.ref039","first-page":"32","article-title":"Biochemical markers and mutation-specific disease severity","volume":"52","author":"S Kim","year":"2019","journal-title":"Clinical Biochemistry"},{"issue":"12","key":"pone.0344034.ref040","first-page":"3456","article-title":"Mutation-driven variations in hematological and biochemical profiles","volume":"5","author":"X Li","year":"2021","journal-title":"Blood Advances"},{"issue":"2","key":"pone.0344034.ref041","first-page":"209","article-title":"Bone health metrics and genetic mutations: A clinical perspective","volume":"33","author":"M F Garcia","year":"2022","journal-title":"Osteoporosis International"},{"issue":"3","key":"pone.0344034.ref042","first-page":"6970","article-title":"Bone health in thalassemia major: A review of current evidence","volume":"9","author":"A Khan","year":"2017","journal-title":"Hematology Reports"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:31:20Z","timestamp":1772649080000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344034"}},"subtitle":[],"editor":[{"given":"Nejat","family":"Mahdieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344034","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}